News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
scanx.trade Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Pembina Pipeline (TSE:PPL) shares have risen above their 200-day moving average, closing at C$68.41 against an average of C$63.87, with analysts maintaining a "Moderate Buy" consensus and an average price target of C$68.86. Several firms adjusted their price targets, with CIBC raising its target …
Wall Street Zen has upgraded Embraer-Empresa Brasileira de Aeronautica (NYSE:EMBJ) from a "hold" to a "buy" rating. The stock opened at $75.33, near its 52-week high, with a market capitalization of $13.61 billion, and maintains a "Moderate Buy" consensus rating among analysts with an …
Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) and its officers, alleging violations of federal securities laws. The lawsuit claims that Embecta made false and misleading statements regarding its business, operations, and prospects between November 25, …
Paradigm BioCapital, along with its related entities and Senai Asefaw, M.D., has reported a collective beneficial ownership of 7.8% in Assembly Biosciences (ASMB), totaling 1,553,748 shares. This stake is based on an amended Schedule 13G filing, with Paradigm BioCapital International Fund Ltd. directly holding …
This article analyzes the price action of Assembly Biosciences Inc. (ASMB), highlighting a mid-channel oscillation pattern and a strong risk-reward short setup. It presents three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis to …
Embraer S.A. (NYSE:EMBJ) gave investors a strong headline and a complicated earnings bridge. The aircraft manufacturer reported record second-quarter revenue of $2.24 billion, up 23% year over year in U.S.-dollar terms, and lifted its 2026 adjusted EBIT margin outlook to 10.0% to 10.6% from …
Sharemaestro market context Price above Trend Line 42 weeks +14.8% · Next-week setup positive 64.6%Assembly Biosciences (NASDAQ:ASMB) saw its shares rise by 8.2% after reporting better-than-expected quarterly earnings, with a loss of $0.20 per share against an anticipated $0.72 loss and revenue of $13.37 million surpassing estimates of $8.60 million. Analysts have a "Moderate Buy" consensus rating with …
This article provides a detailed analysis of Embotelladora Andina S.a. (NASDAQ: AKO.B), highlighting weak near-term sentiment but strong mid and long-term outlooks. It presents three distinct AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to different risk profiles, along with support and resistance levels …
Pembina Pipeline Corp. (PPL) stock increased by 0.46% on Friday, reaching C$68.41, despite a general market downturn where the S&P/TSX Composite Index fell by 0.08%. The company's stock closed 5.9% below its 52-week high of C$72.72. This performance indicates Pembina Pipeline Corp. outperformed the …
Faruqi & Faruqi, LLP is reminding Embecta (EMBC) investors of the August 17, 2026, deadline to seek lead plaintiff status in a federal securities class action lawsuit. The lawsuit alleges that Embecta made misleading statements regarding its financial guidance, particularly concerning its pen needle …
Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit stems from Embecta's Q2 2026 financial results, which were significantly below …
The Gross Law Firm has issued a shareholder alert regarding a securities class action against Embecta Corp. (NASDAQ: EMBC). Shareholders who purchased EMBC shares between November 25, 2025, and May 4, 2026, are encouraged to contact the firm, as the company is accused of …
Embecta's President, Devdatt Kurdikar, recently purchased US$141k worth of company stock at US$4.70 per share, increasing his holding by 3.9%. This is the largest insider purchase in the last year, suggesting optimism for the company's future, despite the overall insider ownership being relatively low …
Embecta Corp.'s Senior Vice President and CFO, Jacob Elguicze, recently purchased 20,000 shares of the company's common stock for $93,360. This insider purchase comes after a significant stock decline but a recent rebound, with the company trading at a low P/E ratio. The purchase …
Embraer will showcase its Ipanema 203 cropduster at the Brazilian Agricultural Aviation Congress from August 18 to 20 in Goianápolis, Goiás. The Ipanema 203, which runs on ethanol and holds over 50% market share, is known for its productivity, precision, and low operating costs. …
Embraer S.A. has approved the payment of R$154 million in Interest on Equity for the third quarter of fiscal year 2026, equating to R$0.21634283532 per ordinary share. This amount will be attributed to the mandatory dividends for the 2026 fiscal year. Shareholders of record …
This article displays the operating cash flow per share for Pembina Pipeline Corp. (OTC: PPLOF) as provided by TradingView. It presents financial data for the company, highlighting the period, value, and change in operating cash flow per share.
Kaplan Fox & Kilsheimer LLP is alerting investors of Embecta Corp. (NASDAQ: EMBC) about a class action lawsuit filed against the company. The lawsuit, on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026, alleges that Embecta misrepresented its …
Pembina Pipeline Corporation (PBA) has filed an updated 2026 Code of Ethics Policy, which applies to all directors, officers, employees, consultants, and contractors. The policy outlines core values such as safety, trustworthiness, respect, collaboration, and entrepreneurship, emphasizing honest, lawful, and ethical conduct. It details …
Morgan Stanley has reduced its beneficial ownership in Embraer S.A. to 3.4% of the common stock, down from a previous holding of over five percent. This information comes from a SCHEDULE 13G/A SEC filing, indicating that Morgan Stanley no longer holds a significant passive …
Assembly Biosciences (NASDAQ:ASMB) reported quarterly earnings, beating analyst expectations with an adjusted loss of $0.20 per share, $0.52 better than forecast, and revenue of $13.37 million, exceeding estimates of $8.60 million. Following the news, shares rose significantly by $2.89 to $29.95 on high trading …
Assembly Biosciences reported its Q2 2026 financial results, revealing a projected cash runway into 2029, bolstered by a recent $115 million financing and an anticipated $75 million payment from Gilead. The company is advancing its ABI-6250 program into Phase 2 studies for cholestatic liver …
Assembly Biosciences, Inc. – Expanded ABI-6250 clinical development into cholestatic liver diseases, including primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) – – Completed $115 million gross financing to support advancement of pipeline programs through key development milestones – – GS-1179 (formerly ABI-1179) …
Rosen Law Firm has issued a reminder to investors regarding a class action lawsuit against Embecta Corp. (NASDAQ: EMBC). The lawsuit alleges that Embecta made misleading statements about its fiscal results and its pen needle business, causing investors to suffer damages. Shareholders who wish …
Search by ticker symbol or company name and select a result to open its chart.